Compelo Medical Devices is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More
Close
Dismiss

MedX Health Takes Over RJ-Laser Canadian Operations

MedX Health, a North American developer and manufacturer of low level laser and light medical devices for the drug free and non-invasive treatment of tissue damage and pain in numerous medical settings including dental, rehabilitation and wound care, has acquired the Canadian operations of Reimers & Janssen (RJ-Laser).

MedX said that it has provided Reimers an expanded line of products, with improved product features, within MedX’s existing rehab/chiropractic, dental, and acupuncture laser and light markets, as well as approved products ready for launch to Veterinarians and Dermatologists.

With the acquisition, RJ-Laser and MedX plan to expand their business partnership throughout 2010. RJ-Laser is currently approved by CE, Health Canada, and recently received FDA approval for many of their laser products.

Steve Guillen, president and CEO of MedX Health, said: “Louie Canitano, the president of RJ-Laser Canada, will be joining the MedX management team as the executive vice president of Operations. Louie has a broad range of skills and expertise within the laser field, acquired over the past 11 years, including design, development, manufacturing, regulatory affairs, and sales and marketing, and his leadership will help accelerate rapid growth of laser and related products and devices within all markets.”

Louie Canitano, president of RJ-Laser Canada, said: “I am excited about joining forces with the MedX team. Together I am confident that we can continue to build upon our existing chiropractic, physiotherapy, dental, and acupuncture markets, and rapidly expand our products into high growth veterinary and dermatology sectors in offering the clinician the widest selection of laser devices and related products creating a one stop laser shop.”